The present invention relates to methods for treating carcinomas or adenocarcinomas using at least one anti-TNF antibody.

 
Web www.patentalert.com

< Antibodies that specifically bind to GMAD

> Process for recombinant expression and purification of antimicrobial peptides using periplasmic targeting signals as precipitable hydrophobic tags

> Vitronectin receptor antagonist derivatives, method for preparing same, use thereof as medicines and pharmaceutical compositions containing same
~ 00595